Haemonetics Corp (HAE)
86.60
+8.44
(+10.80%)
USD |
NYSE |
Nov 07, 16:00
86.60
0.00 (0.00%)
After-Hours: 20:00
Haemonetics Revenue (TTM): 1.334B for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.334B |
| March 31, 2024 | 1.309B |
| December 31, 2023 | 1.270B |
| September 30, 2023 | 1.239B |
| June 30, 2023 | 1.219B |
| March 31, 2023 | 1.169B |
| December 31, 2022 | 1.129B |
| September 30, 2022 | 1.084B |
| June 30, 2022 | 1.026B |
| March 31, 2022 | 993.20M |
| December 31, 2021 | 953.22M |
| September 30, 2021 | 933.82M |
| June 30, 2021 | 903.41M |
| March 31, 2021 | 870.46M |
| December 31, 2020 | 883.93M |
| September 30, 2020 | 902.52M |
| June 30, 2020 | 945.60M |
| March 31, 2020 | 988.48M |
| December 31, 2019 | 999.28M |
| September 30, 2019 | 987.67M |
| June 30, 2019 | 976.68M |
| March 31, 2019 | 967.58M |
| December 31, 2018 | 951.84M |
| September 30, 2018 | 938.52M |
| June 30, 2018 | 922.32M |
| Date | Value |
|---|---|
| March 31, 2018 | 903.92M |
| December 31, 2017 | 898.44M |
| September 30, 2017 | 892.24M |
| June 30, 2017 | 887.11M |
| March 31, 2017 | 886.12M |
| December 31, 2016 | 900.39M |
| September 30, 2016 | 905.94M |
| June 30, 2016 | 905.38M |
| March 31, 2016 | 908.83M |
| December 31, 2015 | 892.97M |
| September 30, 2015 | 891.41M |
| June 30, 2015 | 899.30M |
| March 31, 2015 | 910.37M |
| December 31, 2014 | 924.99M |
| September 30, 2014 | 935.28M |
| June 30, 2014 | 943.45M |
| March 31, 2014 | 938.51M |
| December 31, 2013 | 947.36M |
| September 30, 2013 | 952.64M |
| June 30, 2013 | 935.06M |
| March 31, 2013 | 891.99M |
| December 31, 2012 | 828.72M |
| September 30, 2012 | 772.48M |
| June 30, 2012 | 733.75M |
| March 31, 2012 | 727.84M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
870.46M
Minimum
Mar 2021
1.334B
Maximum
Jun 2024
1.061B
Average
999.28M
Median
Dec 2019
Revenue (TTM) Benchmarks
| Boston Scientific Corp | 15.91B |
| Baxter International Inc | 15.00B |
| Teleflex Inc | 3.026B |
| Cerus Corp | 176.23M |
| Insulet Corp | 1.873B |